363 An ongoing Phase 1 dose-escalation study of the folic acid-tubulysin small-molecule drug conjugate (SMDC) folate-tubulysin EC1456. (September 2015) - Edelman, M.; Matei, D.; Harb, W.; Clark, R.; Sachdev, J.